Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide-Protein Conjugate Vaccines
This article, published in the Journal of Infectious Diseases, reports the results of a study to examine the safety and immunogenicity of two group B Streptococcus (GBS) type V capsular polysaccharide-protein conjugate vaccines. The authors found the GBS type V conjugate vaccines to be safe and immunogenic and conclude that they would be appropriate for inclusion in a candidate multivalent GBS vaccine.
Author: Baker CJ, Paoletti LC, Rench MA, Guttormsen H-K, Edwards MS, Kasper DL
» Visit web page (English)
(Located at academic.oup.com)
Citation: Baker CJ, Paoletti LC, Rench MA, Guttormsen H-K, Edwards MS, Kasper DL. Immune Response of Health Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide-Protein Conjugate Vaccines. Journal of Infectious Diseases. 2004;189(6):1103-1112.
Resource types: Peer-reviewed journal
Diseases/vaccines: Group B Streptococcus (GBS)
Regions: North America and Europe